Praxis Precision Medicines (PRAX) Misses Q4 EPS by 41c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 EPS of ($3.50), $0.41 worse than the analyst estimate of ($3.09).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Argo Graphene raises private placement target to $1.5M
• Smithfield Foods cuts Q3 outlook on fresh pork and hog price pressure